Batavia Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 9.62%
(FY 2022)
- Profit -52.15%
(FY 2022)
- Ebitda 40.48%
(FY 2022)
- Net Worth 17.33%
(FY 2022)
- Total Assets -6.52%
(FY 2022)
About Batavia Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tejas Batavia, Harish Batavia, Vishal Batavia, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304PN2016PTC166674
- Company No.
166674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- LocationPune, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Batavia Pharma Private Limited offer?
Batavia Pharma Private Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Data Entry & Data Processing Service, Data Management, Computer & Mobile Apps Development, Application Development Service, Company Law & Labour Law Consultants, Statutory Compliance Services.
Who are the key members and board of directors at Batavia Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejas Batavia  | Director | 04-Oct-2016 | Current |
| Harish Batavia | Director | 04-Oct-2016 | Current |
| Vishal Batavia | Director | 04-Oct-2016 | Current |
| Tinesh Batavia | Director | 04-Oct-2016 | Current |
Financial Performance of Batavia Pharma.
Batavia Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.62% increase. The company also saw a substantial fall in profitability, with a 52.15% decrease in profit. The company's net worth Soared by an impressive increase of 17.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Batavia Pharma?
Unlock access to Batavia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Batavia Exports International LlpActive 6 years 2 monthsTejas Batavia, Harish Batavia and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Batavia Pharma?
Unlock and access historical data on people associated with Batavia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Batavia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Batavia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
